marketshareAI

MaxCyte, Inc.

MXCTHealthcare
212.20GBX
-1.30%
Market Cap
224.99M
Volume
2.19k
6% of avg
P/E Ratio
-7.07
EPS (TTM)
-0.3
Beta
1.21
Day Range
212.00p - 212.20p
52 Week Range
177.00p212.20p410.00p
212.20p

Upcoming Events

2025 Annual Meeting
MaxCyte may seek shareholder approval to cancel the admission of its common stock from trading on the AIM exchange
High Impact Event
June 18, 2025
Annual Meeting to vote on proposed AIM delisting
High Impact Event
June 25, 2025
Last day of trading on AIM
High Impact Event
June 26, 2025
Cancellation of admission to trading on AIM
High Impact Event
December 31, 2025
Projected cash and investments balance of $160M
High Impact Event
MXCT
BAD

MaxCyte Files Definitive Proxy Statement for AIM Delisting

The healthcare technology company has filed a definitive proxy statement to seek shareholder approval for the cancellation of its shares from trading on the AIM market.

MXCT
NEUTRAL

MaxCyte Announces Director Shareholding Change

The healthcare company has announced a change in a director's shareholding.

MXCT
NEUTRAL

MaxCyte Announces Regulatory Threshold Crossing by BlackRock

The healthcare company has announced that BlackRock has crossed a regulatory threshold in its shareholding.

MXCT
NEUTRAL

BlackRock Increases Stake in MaxCyte

The healthcare technology company reports that BlackRock has increased its stake in the business.

MXCT
GOOD

MaxCyte Announces Proposed Cancellation of AIM Listing

The medical device company plans to cancel its AIM listing to focus on its Nasdaq listing, which it believes will enhance liquidity and reduce costs.

MXCT
NEUTRAL

MaxCyte Announces Regulatory Threshold Crossing by BlackRock

The healthcare company reports a regulatory threshold crossing by major investor BlackRock.

MXCT
NEUTRAL

MaxCyte Announces Change in Substantial Shareholding

The healthcare company reports a change in substantial shareholding by BlackRock, Inc.

MXCT
NEUTRAL

MaxCyte Announces Vesting of RSUs and PDMR Dealing

The healthcare company has announced the vesting of restricted stock units and related share dealings by a senior executive.

MXCT
NEUTRAL

MaxCyte Announces Vesting of RSUs and PDMR Dealing

The healthcare company has announced the vesting of RSUs and a PDMR dealing.

MXCT
NEUTRAL

MaxCyte Announces Change in Substantial Shareholding

The healthcare company announces a change in substantial shareholding by BlackRock, Inc.